Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice.

Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice. - Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030710

Enrollment

Registered

2018-01-10

Start date

2018-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Test food -1 :12-week intake of packaged rice cooked with black brown rice (40%), super-hard rice (40%), and koshihikari brown rice (20%), followed by high pressure treatment (200MPa). Test food -2 :

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Volunteers of higher IAUC responders to white rice in healthy subjects, by finger - prick blood measurement at 0 (pre intake), 15, 30, 45, 60, 90 and 120min post intake of white rice. 2.Fasting plasma glucose = <140mg/dL. 3.Volunteer having screening test result and questionnaire result judged to be appropriate for this study by investigator.

Exclusion criteria

Exclusion criteria: 1.Diabetes under medical treatment. 2.Volunteers having severe diseases (e.g. liver, kindney, heart, blood diseases, and infections requiring the notification) 3.Volunteers received gastrectomy, enterectomy, and gastro-intestinal diseases, juded to be inappropriate for this study. 4.Pregnant, women having the possibility, and lactating women. 5.Volunteers rejected participating in this study by chief investigator.

Design outcomes

Primary

Measure	Time frame
Variables related to blood glucose control (blood glucose level, inslin, HOMA-IR, IAUCg, IAUCi (0-120min)) , safety	—

Secondary

Measure	Time frame
Amyloid beta, HbA1c, AGE, Acceptability	—

Countries

Japan

Contacts

Public ContactHiroshi Goto

Niigata Bio-Research Park, Inc Business promotion division

goto@nbrp.co.jp0250-25-1196

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026